Arcturus Therapeutics Holdings (ARCT) FCF Margin Growth (1y) (2019 - 2026)
Arcturus Therapeutics Holdings (ARCT) FCF Margin Growth (1y) (2019 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 5,389.00 |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 1,525.00 |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Arcturus Therapeutics Holdings | 217.14 Mn | 5.76 Mn | - | -82,322.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -82,322.00 |
| Dec 31, 2025 | -22,624.00 |
| Sep 30, 2025 | -4,249.00 |
| Jun 30, 2025 | 4,078.00 |
| Mar 31, 2025 | -10,481.00 |
| Dec 31, 2024 | 363.00 |
| Sep 30, 2024 | 1,778.00 |
| Jun 30, 2024 | -53,965.00 |
| Mar 31, 2024 | 2,956.00 |
| Dec 31, 2023 | -10,248.00 |
| Sep 30, 2023 | 25,855.00 |
| Jun 30, 2023 | 61,304.00 |
| Mar 31, 2023 | 93,059.00 |
| Dec 31, 2022 | 79,250.00 |
| Sep 30, 2022 | 42,226.00 |
| Jun 30, 2022 | 152,601.00 |
| Mar 31, 2022 | 105,506.00 |
| Dec 31, 2021 | -43,770.00 |
| Sep 30, 2021 | -3,236.00 |
| Jun 30, 2021 | -129,893.00 |